Trametinib-13C D3 | CAS 2712126-59-3 - Request Quote
Trametinib-13C D3
| SZ CAT No: | SZ-T121D03 |
| CAS No | 2712126-59-3 |
| Mol.F. | C2513CH20D3FIN5O4 |
| Mol.Wt. | 619.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Trametinib-13C D3 is chemically N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6-methyl-8-(methyl-13C-d3)-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide. Trametinib-13C D3 is supplied with detailed characterization data compliant with regulatory guideline. Trametinib-13C D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Trametinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2712126-59-3
Purchase 2712126-59-3
Order 2712126-59-3
Enquire 2712126-59-3
price of 2712126-59-3
2712126-59-3 Supplier
2712126-59-3 Manufacturer
2712126-59-3 Exporter
buy high quality Trametinib-13C D3
Purchase Trametinib-13C D3
Trametinib-13C D3 suppliers
Trametinib-13C D3 manufacturers
Trametinib-13C D3 price
Order Trametinib-13C D3
Enquire Trametinib-13C D3
Trametinib-13C D3 cost
Trametinib-13C D3 Supplier
Trametinib-13C D3 Distributor
Trametinib-13C D3 for Method Validation
Trametinib Reference Standard
Trametinib-13C D3 for ANDA Filing
Trametinib-13C D3 for Forced Degradation Studies
Trametinib-13C D3 Identification Standards
Trametinib-13C D3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


